Could donor stem cells free transplant patients from lifelong drugs?
NCT ID NCT04804891
First seen Apr 03, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This early-phase study tests whether giving intestinal transplant patients stem cells from their organ donor can safely reduce the need for strong immunosuppressive drugs. These drugs prevent rejection but raise risks of infection and cancer. The goal is to achieve a state where donor and recipient cells coexist, allowing lower medication doses. Only 6 participants are being enrolled to check safety first.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center/NYP
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.